MOC

Ministry of Digital Transformation of Ukraine and Recorded Future sign Memorandum of Cooperation

Retrieved on: 
Tuesday, December 6, 2022

KYIV, Ukraine and BOSTON, Dec. 6, 2022 /PRNewswire/ -- Ministry of Digital Transformation of Ukraine and Recorded Future, the world's largest intelligence company, today announced the signing of a Memorandum of Cooperation (MoC) to protect critical infrastructure in Ukraine against the military and cyber aggressions by the Russian Federation as well as yielding novel products and technologies for protecting critical infrastructure worldwide.

Key Points: 
  • Ukraine and Recorded Future have a long standing collaboration and relationship in the area of cybersecurity, assisting in the protection of Ukraine's infrastructure and data.
  • Recorded Future will provide its intelligence Platform, its know-how, specialist engineers, and intelligence analysts - including those based in Ukraine itself.
  • The Ministry of Digital Transformation of Ukraine will provide expertise, data, and people.
  • Christopher Ahlberg, CEO/Co-founder of Recorded Future
    About Recorded FutureRecorded Future is the world's largest intelligence company.

Ministry of Digital Transformation of Ukraine and Recorded Future sign Memorandum of Cooperation

Retrieved on: 
Tuesday, December 6, 2022

KYIV, Ukraine and BOSTON, Dec. 6, 2022 /PRNewswire/ -- Ministry of Digital Transformation of Ukraine and Recorded Future, the world's largest intelligence company, today announced the signing of a Memorandum of Cooperation (MoC) to protect critical infrastructure in Ukraine against the military and cyber aggressions by the Russian Federation as well as yielding novel products and technologies for protecting critical infrastructure worldwide.

Key Points: 
  • Ukraine and Recorded Future have a long standing collaboration and relationship in the area of cybersecurity, assisting in the protection of Ukraine's infrastructure and data.
  • Recorded Future will provide its intelligence Platform, its know-how, specialist engineers, and intelligence analysts - including those based in Ukraine itself.
  • The Ministry of Digital Transformation of Ukraine will provide expertise, data, and people.
  • We look forward to working on this imperative challenge with the brilliant team at Ministry of Digital Transformation of Ukraine who has a long history of creative internet solutions. "

Molecure Announces Details for Virtual R&D Day Webcast to be held on Wednesday 7th December 2022

Retrieved on: 
Monday, December 5, 2022

Molecure's most advanced in-house drug candidate is OATD-01, a first-in-class dual chitinase inhibitor for the treatment of interstitial lung diseases, such as sarcoidosis and idiopathic pulmonary fibrosis, that is Phase II ready.

Key Points: 
  • Molecure's most advanced in-house drug candidate is OATD-01, a first-in-class dual chitinase inhibitor for the treatment of interstitial lung diseases, such as sarcoidosis and idiopathic pulmonary fibrosis, that is Phase II ready.
  • A Phase II trial in patients with sarcoidosis is expected to start in 2023.
  • Our second proprietary candidate is OATD-02, an oral, potent and selective first-in-class, dual arginase inhibitor (ARG1 and ARG2) for the treatment of cancer.
  • Molecure's headquarters and laboratories are located in Warsaw, Poland with an additional laboratory facility in d. The company is listed on the Warsaw Stock Exchange (ticker: MOC).

Molecure Announces Details for Virtual R&D Day Webcast to be held on Wednesday 7th December 2022

Retrieved on: 
Monday, December 5, 2022

Molecure's most advanced in-house drug candidate is OATD-01, a first-in-class dual chitinase inhibitor for the treatment of interstitial lung diseases, such as sarcoidosis and idiopathic pulmonary fibrosis, that is Phase II ready.

Key Points: 
  • Molecure's most advanced in-house drug candidate is OATD-01, a first-in-class dual chitinase inhibitor for the treatment of interstitial lung diseases, such as sarcoidosis and idiopathic pulmonary fibrosis, that is Phase II ready.
  • A Phase II trial in patients with sarcoidosis is expected to start in 2023.
  • Our second proprietary candidate is OATD-02, an oral, potent and selective first-in-class, dual arginase inhibitor (ARG1 and ARG2) for the treatment of cancer.
  • Molecure's headquarters and laboratories are located in Warsaw, Poland with an additional laboratory facility in d. The company is listed on the Warsaw Stock Exchange (ticker: MOC).

FAPA and Wheels Up to Host Pilot Hiring Event in Atlanta

Retrieved on: 
Tuesday, November 15, 2022

Pilot career consulting company Future & Active Pilot Advisors (FAPA) is partnering with one of the largest private aviation companies in the world, Wheels Up, to host the Wheels Up Pilot Hiring Event on Wednesday, November 16, 2022, from 8 am-5 pm at the Atlanta Airport Marriott (4711 Best Road Atlanta, GA, 30337).

Key Points: 
  • Pilot career consulting company Future & Active Pilot Advisors (FAPA) is partnering with one of the largest private aviation companies in the world, Wheels Up, to host the Wheels Up Pilot Hiring Event on Wednesday, November 16, 2022, from 8 am-5 pm at the Atlanta Airport Marriott (4711 Best Road Atlanta, GA, 30337).
  • The Wheels Up Pilot Hiring Event follows the New York-City based companys recent announcement of their new Member Operations Center (MOC) to open next year in Chamblee, GA and its recent partnership with Delta Air Lines Propel Pilot Career Path Program.
  • Wheels Up, the only private aviation company on the NYSE, will hold an exclusive pilot recruiting and hiring event near the Atlanta Airport this Wednesday, November 16.
  • Individuals with pilot-in-command experience in various aircraft are invited to register for this free event, says Tim Genc, chief advisor and executive editor of FAPA.

Vinamilk Invests in New "Mega" Dairy Factories to Accelerate Export Supply Capacity

Retrieved on: 
Wednesday, November 16, 2022

The first will see the building of the largest dairy plant in Hung Yen province, and the second being the Moc Chau dairy complex in the northwest going along with the existing factories and farms system of Vinamilk.

Key Points: 
  • The first will see the building of the largest dairy plant in Hung Yen province, and the second being the Moc Chau dairy complex in the northwest going along with the existing factories and farms system of Vinamilk.
  • When finished, these two projects will increase the 20% production capacity of Vinamilk in preparation for the foreseeable future and strengthen the company's position in the market.
  • The Hung Yen dairy plant will connect existing Vinamilk dairy farms, warehouses, and distribution systems to create a sustainable ecosystem and deliver substantial economic benefits.
  • The dairy plant with a total capacity of 400 million liters per year will produce a variety of dairy products to increase supply to Northern Vietnam and for export to ASEAN regions, China, Japan, and South Korea amongst others.

CHILDREN'S HEALTHCARE OF ATLANTA PATIENTS "GIT UP" FOR MUSICAL PERFORMANCE BY BLANCO BROWN WITH MUSICIANS ON CALL AND IHEARTMEDIA AND TREATS FROM EDIBLE®

Retrieved on: 
Monday, November 14, 2022

World-renown recording artist Blanco Brown joined MOC in Children's Seacrest Studios for a musical showcase, including his family dance tune "The Git Up".

Key Points: 
  • World-renown recording artist Blanco Brown joined MOC in Children's Seacrest Studios for a musical showcase, including his family dance tune "The Git Up".
  • Edible also provided gifts and treats to patients and staff at the hospital.
  • "We at Children's Healthcare of Atlanta are extremely grateful for Edible's generous gift of so many adorable stuffed plush animals and delicious treats.
  • Edible pioneered the edible fresh fruit arrangement and now offers fresh fruit smoothies, fresh produce boxes and baked goods both online and at over 1,000 Edible locations worldwide.

Save The Date: Molecure to Host Virtual R&D Day on 7th December 2022

Retrieved on: 
Monday, November 14, 2022

Molecure's most advanced in-house drug candidate is OATD-01, a first-in-class dual chitinase inhibitor for the treatment of interstitial lung diseases, such as sarcoidosis and idiopathic pulmonary fibrosis, that is Phase II ready.

Key Points: 
  • Molecure's most advanced in-house drug candidate is OATD-01, a first-in-class dual chitinase inhibitor for the treatment of interstitial lung diseases, such as sarcoidosis and idiopathic pulmonary fibrosis, that is Phase II ready.
  • A Phase II trial in patients with sarcoidosis is expected to start in 2023.
  • Our second proprietary candidate is OATD-02, an oral, potent and selective first-in-class, dual arginase inhibitor (ARG1 and ARG2) for the treatment of cancer, which is expected to advance to Phase I clinical development in the second half of 2022.
  • Molecure's headquarters and laboratories are located in Warsaw, Poland with an additional laboratory facility in d. The company is listed on the Warsaw Stock Exchange (ticker: MOC).

Save The Date: Molecure to Host Virtual R&D Day on 7th December 2022

Retrieved on: 
Monday, November 14, 2022

Molecure's most advanced in-house drug candidate is OATD-01, a first-in-class dual chitinase inhibitor for the treatment of interstitial lung diseases, such as sarcoidosis and idiopathic pulmonary fibrosis, that is Phase II ready.

Key Points: 
  • Molecure's most advanced in-house drug candidate is OATD-01, a first-in-class dual chitinase inhibitor for the treatment of interstitial lung diseases, such as sarcoidosis and idiopathic pulmonary fibrosis, that is Phase II ready.
  • A Phase II trial in patients with sarcoidosis is expected to start in 2023.
  • Our second proprietary candidate is OATD-02, an oral, potent and selective first-in-class, dual arginase inhibitor (ARG1 and ARG2) for the treatment of cancer, which is expected to advance to Phase I clinical development in the second half of 2022.
  • Molecure's headquarters and laboratories are located in Warsaw, Poland with an additional laboratory facility in d. The company is listed on the Warsaw Stock Exchange (ticker: MOC).

Chris Young, Jamie O’Neal, Craig Morgan and More Share Gratitude with Hospitalized Veterans Through Exclusive Concerts from Musicians On Call

Retrieved on: 
Thursday, November 10, 2022

NASHVILLE, Nov. 10, 2022 (GLOBE NEWSWIRE) -- This Veterans Day, and all month long, hospitalized Veterans in all Veterans Affairs (VA) facilities nationwide will have the opportunity to feel the deep appreciation they deserve through the healing power of music. Musicians On Call (MOC), a nonprofit that brings live and recorded music to the bedsides of patients, families and caregivers in healthcare environments, has teamed up with Wrangler® and award-winning recording artists on Concert For Veterans Presented by Wrangler, an initiative that offers hope and happiness that only live music can provide.

Key Points: 
  • Also part of this years campaign is the Concert For Veterans Live!, a concert experience for Veterans at the Alvin C. York VA Medical Center in Murfreesboro, Tenn.
  • Hosted by Warner Music Nashville, this concert featured performances by recording artists Tyler Braden and Drew Parker live from the Murfreesboro campus.
  • At Musicians On Call we are passionate about delivering the healing power of music to Veterans every day through our bedside, virtual and streaming programs.
  • Visit www.musiciansoncall.org to see highlights from Concert For Veterans Presented by Wrangler and donate to MOCs Veterans programs.